Functional Skills
Business Analysis
Business Development
Corporate Finance
Financial Modeling
Market Research
Strategic Planning
Strategy Development
M&A Deal Sourcing
M&A Support
Business Unit Strategy
Geographic Market Entry
Commercial Due Diligence
Private Equity Investing
Competitive Landscaping
Venture Capital Investing
Software Skills
Data visualization
Microsoft Excel
Microsoft PowerPoint
Certifications
CFAChartered Financial Analyst
Sector Experience
Agriculture
Energy
Financial Services
Life Sciences & Pharma
Technology
Big 4 Accounting
Top Consulting Firms
Experience
Aoraki Ventures
Management Consulting
Independent Strategy and M&A Advisor
8/2024 - Present
▪ Advising PE and PE-backed companies commercial due diligence, deal execution, and value creation plan
▪ Advising portfolio companies on investment readiness, strategic pivot, and fundraising strategy
[Detailed project list available]
▪ Advising portfolio companies on investment readiness, strategic pivot, and fundraising strategy
[Detailed project list available]
NLC Health Ventures
Start-Up
Interim Investment Manager
9/2024 - 3/2025
• Led 3 end-to-end investments, synthesizing DD findings, developed rNPV valuations, and presented investment cases to the IC
• Improved projected fund IRR by 3x by developing a new investment model tailored to risk profile
• Conducted strategic review of portfolio companies and defined action plans for fundraising readiness and expansion strategies
• Improved projected fund IRR by 3x by developing a new investment model tailored to risk profile
• Conducted strategic review of portfolio companies and defined action plans for fundraising readiness and expansion strategies
Surmount Ventures
Finance
Investment Manager
3/2021 - 4/2024
• Defined and executed growth strategies, including platform creation, market entry, and strategic M&A
• Led buy-and-build strategy with 6 acquisitions and spun off 3 ventures from biotech platform in addition to 3 strategic bolt-ons
• Developed corporate strategies for 3 portfolio companies and devised market entry strategies for AHV to unlock 23 countries
• Initiated investment theses in AI and digital health, sourcing and evaluating over 30 opportunities
• Active portfolio management, including raising a €10m+ growth round (mezzanine) of a portfolio company and leading the sell side process for a platform investment (encompassing 4 portfolio companies), securing 4 NBOs from Trans-Atlantic PE firms
• Interim executive director in a biotech portfolio company and led the development and financing activities alongside the CEO
• Led buy-and-build strategy with 6 acquisitions and spun off 3 ventures from biotech platform in addition to 3 strategic bolt-ons
• Developed corporate strategies for 3 portfolio companies and devised market entry strategies for AHV to unlock 23 countries
• Initiated investment theses in AI and digital health, sourcing and evaluating over 30 opportunities
• Active portfolio management, including raising a €10m+ growth round (mezzanine) of a portfolio company and leading the sell side process for a platform investment (encompassing 4 portfolio companies), securing 4 NBOs from Trans-Atlantic PE firms
• Interim executive director in a biotech portfolio company and led the development and financing activities alongside the CEO
HHV Biotech
Start-Up
Venture Builder - Founding Team
3/2021 - 2/2022
Biotech venture creation by Surmount; part of the two-person founding team
▪ Strategy: Identified and prioritized top-3 medical indications based on market, clinical development, and route of administration
▪ Corporate Finance: Built scenario-based financial models with clear decision point logic and secured €5m in initial financing
▪ R&D Planning: Mapped out a full preclinical development plan in collaboration with academic partners and CROs
▪ Partnerships: Interviewed KOLs, selected CROs/CDMOs and coordinated R&D activities across 7 external research sites
▪ Team Management: Facilitated cross-functional workshops with scientists and advisors to solve critical development challenges
▪ Strategy: Identified and prioritized top-3 medical indications based on market, clinical development, and route of administration
▪ Corporate Finance: Built scenario-based financial models with clear decision point logic and secured €5m in initial financing
▪ R&D Planning: Mapped out a full preclinical development plan in collaboration with academic partners and CROs
▪ Partnerships: Interviewed KOLs, selected CROs/CDMOs and coordinated R&D activities across 7 external research sites
▪ Team Management: Facilitated cross-functional workshops with scientists and advisors to solve critical development challenges
Strategy&
Management Consulting
Manager
9/2018 - 2/2021
• Delivered 20+ strategic advisory projects, including market entry, corporate strategy, and commercial due diligence
• Defined and implemented corporate strategy roadmaps and GTM strategies for PE portfolio companies
• Achieved operational turnaround for hospitality client during COVID-19 through cross-functional cost-savings
• Managed all aspects of client communications from scoping to presenting project deliverables; led and coached project teams
• Defined and implemented corporate strategy roadmaps and GTM strategies for PE portfolio companies
• Achieved operational turnaround for hospitality client during COVID-19 through cross-functional cost-savings
• Managed all aspects of client communications from scoping to presenting project deliverables; led and coached project teams
PricewaterhouseCoopers (PwC)
Management Consulting
Associate
9/2016 - 8/2018
▪ Corporate finance: Buy side and sell side deal origination and execution with a focus on cross-border mid-market transactions
▪ Valuation: Financial modeling using various methods, including DCF, LBO, Multiples, with a focus on financial services
▪ Commercial due diligence: Market sizing, competitor & value chain analyses, expert interviews, and business plan assessments
▪ Financial due diligence: Quality of earnings, EV to equity bridge (net debt, net working capital)
▪ Valuation: Financial modeling using various methods, including DCF, LBO, Multiples, with a focus on financial services
▪ Commercial due diligence: Market sizing, competitor & value chain analyses, expert interviews, and business plan assessments
▪ Financial due diligence: Quality of earnings, EV to equity bridge (net debt, net working capital)
Oliver Wyman
Management Consulting
Summer Management Consultant
6/2015 - 8/2015
Managed the PMO for the Asset Liability Management division of a top-3 Dutch bank as part of the bank’s broader IPO process